TN's Covid survey shows 97 per cent of elderly population has protective immunity
CHENNAI: A serosurvey for Covid-19 conducted by the Directorate of Public Health (DPH) and Preventive Medicine among elderly people in six districts of Tamil Nadu in the month of April has shown 97% of the surveyed population to have protective levels of immunity.
The results showing high seroprevalence of SARS CoV-2 IgG antibodies, coming amid concerns of a surge in number of Covid-19 cases, showed that the infections by SARS CoV-2 virus could not cause severe illness, the health department said. It added that deaths due to Covid-19 are almost nil in TN.
According to the DPH, a total of 3,643 blood samples were collected from persons as part of the elderly panel survey in Chennai, Tiruvallur, Tiruvannamalai, Tiruchy, Dharmapuri and Kanniyakumari districts.
'Preliminary analysis of 1,214 samples tested for SARS-CoV antibodies (IgG) showed the protective levels of immunity to be 97%,' a DPH release said.
The press release said that even after a gap of three years in conducting the present Phase V of the serosurvey, the prevalence of protective level of SARS CoV antibodies is very high and significant.
Effective vaccination drives implemented by the state government might be responsible for the high level of protection against SARS CoV-2 virus, it said.
'In addition, natural infection and subclinical infection due to the weakened circulating Omicron sub lineage of SARS CoV-2 virus could have also enhanced the development of antibodies,' the release added. The state has not officially released data on Covid-19 cases after the recent surge across the country.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
Ludhiana: Three more test +ve for COVID, tally reaches 29
Three new COVID-19 cases were reported in the district on Thursday, taking the tally total to 29 cases. The new cases include three women aged 17,18, and 29 respectively. While one is reported to be asymptomatic, the rest are only mildly symptomatic. Earlier on Wednesday, no positive cases were reported in the district. Of the total 26 cases reported so far, only 13 are positive at present. All these 13 are only mildly symptomatic and in home isolation. 14 people have recovered so far. Two people, one 40-year-old man and another 69-year-old lady, both suffering from comorbid conditions, have died of the infection. All the people reported positive have been vaccinated for COVID-19, except an 18-year-old.
Time of India
7 hours ago
- Time of India
Delhi govt to discontinue bike ambulance service
N ew Delhi: Delhi govt has decided to discontinue the bike ambulance service launched by AAP govt in Feb 2019 after finding it unsuitable in the city's extreme weather conditions. The bike ambulance service was started in 2019 by the previous AAP govt. It was aimed at providing first aid for emergencies at home. The then govt launched 16 first-responder bikes, which operated in east, north-east Delhi, and Shahdara as part of a pilot project. The scheme was halted because of the Covid lockdown in 2020, but there were plans to give it a fresh push last year. Senior officials, however, said that they have now handed over the bikes to the general administration department of Delhi govt, and there have been suggestions if they can be used by the fire department. "Delhi mostly has extreme weather conditions. Also, there is a tendency among patients to call emergency services like ambulances mostly when they are critical. For critical patients, it is difficult to sit on a bike," an official said. The official mentioned that govt would instead focus more on expanding vans as ambulance services. Officials said govt plans to enhance its emergency medical response capabilities by incorporating 103 additional ambulances into the Centralised Accident and Trauma Service (CATS). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo The expansion, which aims to bolster urgent healthcare services across Delhi, includes the procurement of 50 geriatric-friendly advanced life support (ALS) ambulances that will be operated by an outsourced agency, officials said. Private ambulance operators have been invited to submit applications for 53 basic life support (BLS) vehicles, including drivers and qualified paramedical staff. While starting the bike ambulance service, the then AAP govt had said that two-wheelers can reach places where four-wheelers cannot. In many cases requiring medical attention, a few minutes can mean a difference between life and death. "These bike ambulances are handy as they can reach the site quickly in congested areas, provide first aid, and stabilise a patient's condition before an ambulance arrives. They also inform the control room about the case, if required," it said. Officials, however, said that the bike ambulances are more useful in areas with rough terrain where cars cannot reach at all, but in Delhi, that is not the case. These bike ambulances were equipped with kits, weighing 30kg, that contained air splints to immobilise joints, ambu bags for assisted breathing, a glucometer and a pulse oximeter to check a person's blood glucose and oxygen saturation. They also had a manual suction machine to clear airways and foldable transfer sheets to move patients in a narrow stairwell or from a narrow lane to the ambulance. Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .
Time of India
7 hours ago
- Time of India
Bharat Biotech in-licences GSK's Shigella vaccine
Hyderabad: Vaccine maker Bharat Biotech International Limited (BBIL) has in-licensed pharma giant GSK's under development Shigella vaccine candidate, altSonflex1-2-3. The vaccine candidate was being developed by GSK against Shigellosis, a severe form of bacterial diarrhoea that largely affects children aged below five years in low- and middle-income countries. While GSK has already conducted Phase I and II trials in Europe and Africa, Bharat Biotech will take up further development with Phase III clinical trials, regulatory advancement, and large-scale manufacturing, the Hyderabad-based vaccine maker said on Thursday. As part of the agreement, GSK will continue to support the programme by assisting with clinical trial design, securing external funding, and contributing to the access and delivery plans and commercialisation strategy. The vaccine has been developed on the innovative generalised modules for membrane antigens (GMMA) based platform, which uses bacterial outer membranes to deliver the O Antigen to the immune system. "The in-licensed candidate, altSonflex1-2-3, already showed encouraging results in early-stage clinical trials. A Phase 1 study conducted in Europe demonstrated a favourable safety profile and strong immune response," Bharat Biotech said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Toulouse: Nous recherchons des personnes pour tester les nouvelles aides auditives HearPro En savoir plus Undo "Subsequent Phase 2 trials in Africa, including vaccination of 9-month-old infants—the primary target population—reported no safety concerns. Interim results from 2024 confirmed that the candidate met its pre-set immunogenicity goals," it added. Bharat Biotech Executive Chairman Dr Krishna Ella said: "With no approved vaccine currently available for Shigella and antimicrobial resistance on the rise, there is an urgent need for scalable, science-backed solutions focused on low and middle-income countries. This collaboration combines our strengths in innovation, manufacturing, and global health commitment." He pointed out that Bharat Biotech already has a significant presence in vaccines for diarrhoeal infections, including rotavirus, typhoid, polio, non-typhoidal salmonella, cholera, and paratyphi. In 2021, GSK had inked a product transfer agreement for the world's first malaria vaccine, RTS,S, with Bharat Biotech. Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .
